Sanofi and Eurapharma team up to boost Maphar's operations
Europharma, a subsidiary of CFAO group, a multinational company engaged in the sale of manufactured pharmaceutical products in Africa, has just signed a partnership agreement with Sanofi which will start operating in June 2017. The objective is to boost and promote the development of Maphar, the Moroccan subsidiary of Sanori in the African market, Le Figaro reports.
Eurapharma will be granted 51% of Maphar’s stake, a promotion plan for the Moroccan and African markets, and cooperation